v3.26.1
CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Operating expenses:                
Research and development $ 7,425   $ 24,091   $ 14,259 $ 31,987 $ 44,923 $ 41,488
General and administrative 2,592   3,201   5,863 6,927 12,693 15,718
Restructuring and asset impairment charges 5,077       5,077     2,542
Total operating expenses 15,094   27,292   25,199 38,914 57,616 59,748
Loss from operations (15,094)   (27,292)   (25,199) (38,914) (57,616) (59,748)
Other income, net 202   484   511 1,130 1,772 4,094
Net loss $ (14,892) $ (9,796) $ (26,808) $ (10,976) $ (24,688) $ (37,784) $ (55,844) $ (55,654)
Net loss per common share                
Basic (in dollars per share) $ (2.8)   $ (11.29)   $ (4.68) $ (16.05) $ (19.65) $ (23.88)
Diluted (in dollars per share) $ (2.8)   $ (11.29)   $ (4.68) $ (16.05) $ (19.65) $ (23.88)
Weighted average shares outstanding                
Basic (in shares) 5,309,724   2,374,729   5,274,630 2,354,425 2,842,448 2,330,386
Diluted (in shares) 5,309,724   2,374,729   5,274,630 2,354,425 2,842,448 2,330,386
Comprehensive loss:                
Net loss $ (14,892) $ (9,796) $ (26,808) $ (10,976) $ (24,688) $ (37,784) $ (55,844) $ (55,654)
Unrealized loss on marketable securities (1)   (7)   (24) (11) 17 226
Total comprehensive loss $ (14,893)   $ (26,815)   $ (24,712) $ (37,795) $ (55,827) $ (55,428)